Vident Advisory, LLC Grifols Sa Transaction History
Vident Advisory, LLC
- $5.7 Trillion
- Q4 2024
A detailed history of Vident Advisory, LLC transactions in Grifols Sa stock. As of the latest transaction made, Vident Advisory, LLC holds 29,662 shares of GRFS stock, worth $217,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,662
Previous 19,072
55.53%
Holding current value
$217,125
Previous $169 Million
30.31%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GRFS
# of Institutions
169Shares Held
146MCall Options Held
166KPut Options Held
103K-
Capital World Investors Los Angeles, CA21.1MShares$155 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA20.5MShares$150 Million1.82% of portfolio
-
Permian Investment Partners, LP New York, NY16.2MShares$118 Million21.69% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.3MShares$82.4 Million3.99% of portfolio
-
Armistice Capital, LLC New York, NY10MShares$73.5 Million1.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $4.97B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...